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Purpose: Although the data are promising from limited studies with technetium-99m 
ubiquicidin scintigraphy in detection of infection in humans, these studies have had a 
limited sample size. This study was conducted to provide a systematic review and 
meta-analysis of the reported diagnostic accuracy of 99mTc-UBI scintigraphy in 
detection of an infectious process. 
Materials and methods: The PubMed/MEDLINE, Web of Science, EMBASE, and 
Google Scholar literature databases were systematically searched to find the relevant 
human studies on 99mTc-UBI scintigraphy. For each eligible study, the true-positive, 
false-positive, true-negative and false-negative findings at 99mTc-UBI scintigraphy 
were recorded, and the overall statistical parameters were acquired.  
Result: Ten studies carried out from 2004 to 2010 were included in the analysis. The 
pooled data sensitivity was 97.5% with the 95% confidence interval of 94.9%–99.0%. 
The pooled specificity was still as high as about 89%. The range of reported 
specificity was from 80 to 100%. The overall accuracy was 93.7 % (95% CI: 91.2%–
95.7%). 
Conclusion: The study demonstrated that 99mTcUBI scintigraphy can be used to 
identify an infectious process with admirable accuracy in early views; however, 
further investigations are recommended. 
 
Key words:  99mTc-UBI scan, antimicrobial peptides, infection  
 3 
Introduction 
The prompt and timely clinical diagnosis of infection can be challenging, but it is 
associated in a crucial way with a patient's care management. Current available 
radiopharmaceuticals are often unable to differentiate between sterile inflammation 
and infection. Several pharmaceuticals labeled with various radioisotopes, such as 
liposomes labeled with 99m technetium (1), immunoglobulins (2, 3), the avidin–
biotin system (4), antigranulocyte antibodies and antibody fragments, chemotactic 
peptides, cytokines, interleukins, platelet factor-4, and Ciprofloxacin labeled with 
99mTc (5) have been applied, but an optimal radiotracer has not yet been established. 
Therefore, autologous leukocytes labeled with 111In or 99mTc-HMPAO are still 
considered the gold standard despite their limitations (6). Consequently, the practice 
of directly targeting infectious agents with radiolabeled antibiotics or antimicrobial 
peptides was introduced (7), and a number of radiolabeled peptides have been 
assessed (8, 9). Among the several radiolabeled peptides options, technetium-99m 
(99mTc) labeled cationic antimicrobial peptides originating from ubiquicidin (UBI) 
are increasingly used in the diagnostic evaluation of patients (10, 11).  
Although results from limited preclinical and pilot studies in patients are promising 
(12, 13), they had a limited sample size.  So we have performed a meta-analysis of 
diagnostic studies regarding the accuracy of 99mTc-UBI 29-41 scintigraphy in the 
identification of infection. 
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Materials and methods  
Identification and eligibility of pertinent investigations 
The attempt was made to identify all investigations regarding the diagnostic accuracy 
of ubiquicidin (UBI) labeled with technetium 99m (99mTc) for detection of infection 
in patients.  
All pertinent investigations were included, not considering the type of UBI used and 
regardless of the location of disease. The PubMed/MEDLINE, Web of Science, 
EMBASE, and Google Scholar literature records were systematically searched for 
publications from January 1965 up to September 2012. The search strategy was based 
on the terms “99mTc-ubiquicidin scintigraphy,” “99mTc-UBI scintigraphy,” 
“antimicrobial peptides scan using UBI,” “ubiquicidin scan,” and “UBI scan.”  
Experimental investigations on animals were excluded.   
 
 
